Enanta Pharmaceuticals (NASDAQ:ENTA) reported quarterly losses of $(1.27) per share which beat the analyst consensus estimate of $(1.35) by 5.93 percent. This is a 4.1 percent decrease over losses of $(1.22) per share
IonQ signs Memorandum of Understanding (MoU) to promote educational programs and joint research in quantum computing for Seoul National UniversityIonQ (NYSE:IONQ), a leader in the quantum computing industry, signed a